Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021

This case-control study examines estimated COVID-19 messenger RNA vaccination effectiveness against SARS-CoV-2 infection from January to September 2021 among fully vaccinated male veterans aged 65 years or older.

Detalles Bibliográficos
Autores principales: Young-Xu, Yinong, Zwain, Gabrielle M., Powell, Ethan I., Smith, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674742/
https://www.ncbi.nlm.nih.gov/pubmed/34910155
http://dx.doi.org/10.1001/jamanetworkopen.2021.38975
_version_ 1784615740527083520
author Young-Xu, Yinong
Zwain, Gabrielle M.
Powell, Ethan I.
Smith, Jeremy
author_facet Young-Xu, Yinong
Zwain, Gabrielle M.
Powell, Ethan I.
Smith, Jeremy
author_sort Young-Xu, Yinong
collection PubMed
description This case-control study examines estimated COVID-19 messenger RNA vaccination effectiveness against SARS-CoV-2 infection from January to September 2021 among fully vaccinated male veterans aged 65 years or older.
format Online
Article
Text
id pubmed-8674742
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-86747422022-01-04 Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021 Young-Xu, Yinong Zwain, Gabrielle M. Powell, Ethan I. Smith, Jeremy JAMA Netw Open Research Letter This case-control study examines estimated COVID-19 messenger RNA vaccination effectiveness against SARS-CoV-2 infection from January to September 2021 among fully vaccinated male veterans aged 65 years or older. American Medical Association 2021-12-15 /pmc/articles/PMC8674742/ /pubmed/34910155 http://dx.doi.org/10.1001/jamanetworkopen.2021.38975 Text en Copyright 2021 Young-Xu Y et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Young-Xu, Yinong
Zwain, Gabrielle M.
Powell, Ethan I.
Smith, Jeremy
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
title Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
title_full Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
title_fullStr Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
title_full_unstemmed Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
title_short Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
title_sort estimated effectiveness of covid-19 messenger rna vaccination against sars-cov-2 infection among older male veterans health administration enrollees, january to september 2021
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674742/
https://www.ncbi.nlm.nih.gov/pubmed/34910155
http://dx.doi.org/10.1001/jamanetworkopen.2021.38975
work_keys_str_mv AT youngxuyinong estimatedeffectivenessofcovid19messengerrnavaccinationagainstsarscov2infectionamongoldermaleveteranshealthadministrationenrolleesjanuarytoseptember2021
AT zwaingabriellem estimatedeffectivenessofcovid19messengerrnavaccinationagainstsarscov2infectionamongoldermaleveteranshealthadministrationenrolleesjanuarytoseptember2021
AT powellethani estimatedeffectivenessofcovid19messengerrnavaccinationagainstsarscov2infectionamongoldermaleveteranshealthadministrationenrolleesjanuarytoseptember2021
AT smithjeremy estimatedeffectivenessofcovid19messengerrnavaccinationagainstsarscov2infectionamongoldermaleveteranshealthadministrationenrolleesjanuarytoseptember2021

Ejemplares similares